Stock Price Quote

BOMBAY BURMAH TRADING CORPORATION LTD.

NSE : BBTCBSE : 501425ISIN CODE : INE050A01025Industry : AgricultureHouse : Wadia
BSE1568.50-13.05 (-0.83 %)
PREV CLOSE ( ) 1581.55
OPEN PRICE ( ) 1598.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6812
TODAY'S LOW / HIGH ( )1557.00 1610.00
52 WK LOW / HIGH ( )918.3 1838
NSE1569.10-9.8 (-0.62 %)
PREV CLOSE( ) 1578.90
OPEN PRICE ( ) 1583.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1569.10 (538)
VOLUME 75616
TODAY'S LOW / HIGH( ) 1556.55 1613.15
52 WK LOW / HIGH ( )918 1839.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1863
Management Info
Nusli N Wadia - Chairman Ness N Wadia - Managing Director
Registered Office

Address 9 Wallace Street,Fort, ,
Mumbai,
Maharashtra-400001

Phone 022-22197101

Email writetous@bbtcl.com

Website www.bbtcl.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

23Apr Clarification sought from Bombay Burm
The Exchange has sought clarification from Bombay Burmah Trading Corpora..
13Feb Announcement Under Regulation 30 (LOD
Announcement under Regulation 30 (LODR) - Appointment of Senior Management
27Jul Bombay Burmah Trading Corp informs abo
Bombay Burmah Trading Corp has informed that the exchange has received t..
27May The Bombay Burmah Trading Corporation
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Req..
27May The Bombay Burmah Trading Corporation
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclo..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit-314.4587.8599999999997
Gross Profit -312.48 -2292.41
Operating Profit -159.25514.47
Net Sales 597.812445.88

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kaveri Seed (BSE)
peergroup  879.75 (5.36%)
M.Cap ( in Cr)4525.35
Indo US Bio-Tech (BSE)
peergroup  235.00 (8.77%)
M.Cap ( in Cr)471.22
Venkys India (BSE)
peergroup  1803.60 (0.85%)
M.Cap ( in Cr)2540.79
Nath Bio-Genes (BSE)
peergroup  207.20 (3.83%)
M.Cap ( in Cr)393.76
JK Agri Genetics (BSE)
peergroup  409.00 (1.65%)
M.Cap ( in Cr)189.65

Shareholding Pattern

PROMOTERS 74.05%
NON-INSTITUTION 15.71%
FI/BANKS/INSURANCE 0.56%
MUTUAL FUNDS/UTI 0.05%
GOVERNMENT 0%
FII 0%

About Bombay Burmah Trading Corporation Ltd.

Bombay Burmah Trading Corporation Ltd. was incorporated in the year 1863. Its today's share price is 1568.5. Its current market capitalisation stands at Rs 10943.72 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2502.42 Cr and Total Income of Rs.3346.83 Cr. The company's management includes Murli Manohar Purohit, Chandra Iyengar, Vinesh Kumar Jairath, YSP Thorat, Rajesh Batra, Minnie Bodhanwala, Ness N Wadia, Nusli N Wadia.

It is listed on the BSE with a BSE Code of 501425 , NSE with an NSE Symbol of BBTC and ISIN of INE050A01025. It's Registered office is at 9 Wallace Street,Fort, Mumbai-400001, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co, BSR & Co LLP, CC Chokshi & Co, Deloitte Haskins & Sells, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.